A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study

2020130 citationsJournal Articlegreen Open Access

Authors

This trial suggests that PE with albumin replacement could slow cognitive and functional decline in AD, although further studies are warranted.

Partnerships for the goals

Published in: Alzheimer s & Dementia

Volume 16, Issue 10, pp. 1412-1425

Field-Weighted Citation Impact: 9.47